Research

IUD in hand

Research projects are continuously being developed and implemented within the Family Planning Division. Past and present research includes evaluating the effectiveness and satisfaction of a levonorgestrel-releasing intrauterine system (IUD) for long-term, reversible contraception and the effectiveness of the insertion device. Faculty members within the Obstetrics & Gynecology department have developed a semi-quantitative pregnancy test that is being studied for post-abortion care and in vitro fertilization (IVF) treatment, and a dedicated IUD inserter for use in post delivery settings both domestically and internationally.

Fellowship research projects have included simplifying methods for IUD insertion and improving patient access and experience during 2nd trimester pregnancy termination by evaluating the effectiveness of Mifepristone during treatment.

 

A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception

The primary objective of this study is to assess the efficacy of a levonorgestrel-releasing intrauterine system (LNG20) in nulliparous and parous females of child-bearing potential who request long-term, reversible contraception for up to 7 years. This study is ongoing, but is not recruiting patients.

Principal Investigator: Paul D Blumenthal, MD, MPH

 

Comparative Study of Menstrual Blood and Systemic Blood: Quantifying the Difference

The primary objective of this study is to assess if menstrual blood could be utilized as a natural and non-invasive way of accessing blood samples for health monitoring and diagnosis. This study is currently recruiting participants. Please e-mail familyplanningresearch@stanford.edu for more information.

Student Investigator: Sara Naseri

 

Measuring hCG Levels in Pregnant Women: A Prenatal Study of hCG Using a Multi-Level Pregnancy Test and Serum Testing

Understanding hCG patterns among women over 63 days gestation is important for developing strategies for pregnancy testing in a number of populations. This study  seeks assess trends in hCG between the 9th and 12th weeks of gestation by comparing blood hCG serum levels with the results of a multi-level pregnancy test (MLPT). This study is actively seeking participants, please e-mail familyplanningresearch@stanford.edu for more information. 

Principal Investigator: Paul D Blumenthal, MD, MPH

 

Self-Administered Lidocaine Gel for Uterine Devices (SALUD) 

The primary objective of this study is to investigate the use of lidocaine gel for pain control during intrauterine device (IUD) insertion and endometrial biopsy. This study is enrolling and is currently recruiting patients presenting to the Gynecology Clinic seeking IUD insertion. If you would like to participate or you have questions, please contact familyplanningresearch@stanford.edu.

Principal Investigator: Jennifer Conti, MD, MS

 

Labor and Delivery Implant Insertion (LADII): A randomized controlled trial

The objective of this study is to compare the immediate insertion of the contraceptive implant to delayed insertion (before hospital discharge following delivery) and breastfeeding outcomes between timing of insertion. This study is ongoing and currently recruiting patients presenting to labor and delivery who desire a contraceptive implant for postpartum contraception. Please contact us for more information familyplanningresearch@stanford.edu.

Principal Investigator: Kate A. Shaw, MD, MSc

For more information about any current or past research projects or inquiries about potential collaboration or participation, please e-mail: 
familyplanningresearch@stanford.edu